Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease

Clinical trial NCT07417670 · COMPLETED

Trial details

NCT number: NCT07417670
Sponsor: Carnot Laboratories
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2024-10-04
Primary completion: 2025-08-12
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.